Editor's Note Nearly 20 years of data on the first 50 face transplants in the world indicate that survival rates exceed those of several solid organ transplants, according to a global study published September 18 in Jama Surgery. Conducted between 2005 and 2021, the study involved 18 transplant centers, assessed…

Read More

Editor's Note An analysis of two phase-III trials showed adjuvant administration of nivolumab (Opdivo) plus chemotherapy reduces the risk of recurrence or death in patients with resectable non-small cell lung cancer (NSCLC) by 40% compared to neoadjuvant nivolumab plus chemotherapy alone, Medpage Today reported September 9. "With the caveat that…

Read More

Editor's Note A panel discussion at last year’s OR Manager Conference highlighted the benefits and challenges of introducing robotics into ambulatory surgery centers (ASCs), particularly for joint replacement surgical procedures. Hosted by Surgical Care Affiliates (SCA) and Stryker leaders, the session emphasized how robotic technology can help improve surgical outcomes,…

Read More

Editor's Note Aaron James says he’s “pretty much back to being a normal guy, doing normal things” a year after undergoing the world’s first whole-eye and partial-face transplant at NYU Langone Health, according to a September 9 report from the academic medical center. The transplant restored essential facial functions, and…

Read More

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

Editor's Note A recent study conducted across 185 hospital wards in England highlights the significant impact of nurse staffing levels and staff composition on patient mortality. Published August 19 in JAMA, the study analyzed data from over 626,000 hospital admissions between 2015 and 2020. It found that low staffing levels…

Read More

Editor's Note Optimizing patient positioning can help reduce the risk of surgical site infections due to airborne contaminants in positive-pressure ORs, according to a study published August 12 in Nature: Scientific Reports. Maintaining higher pressure than adjacent spaces prevents entry of contaminants from environments external to the OR. For this…

Read More

Editor's Note An electronic health record (EHR)-based nudge could significantly reduce low-value axillary surgeries in older women with early-stage breast cancer, researchers reported July 17 in JAMA Surgery. Conducted across eight clinical settings, the initiative significantly cut the rates of low-value sentinel lymph node biopsies (SLNB) by nearly 50% over…

Read More

Editor's Note Acquisition by private equity firms leaves healthcare facilities less equipped to care for patients, according to a recent study published in JAMA. NBC reported the news July 31. Conducted by researchers from the University of California at San Francisco, Harvard Medical School, and Hunter College, this nationwide study…

Read More

Takeaways Transmitting health metrics directly from a surgical implant reduces the need for in-person followup and offers more objective data on recovery than patient-reported measures. This technology’s potential extends beyond knees. Whatever the nature of the treatment, postop monitoring is critical. Patient education is essential for setting up the data…

Read More